Candel Therapeutics (CADL) EBIT Margin (2020 - 2023)
Candel Therapeutics (CADL) recorded EBIT Margin of -9444.12% in Q1 2023, up 19542.98 percentage points from -28987.10% a year earlier and up 16688.14 percentage points from the prior quarter.
Powered by 
Analysis
Candel Therapeutics (CADL) EBIT Margin (2020 - 2023) Analysis & Trends
On a TTM basis, Candel Therapeutics' EBIT Margin came in at -18137.44% as of Mar 31, 2023, up 6101.27 percentage points year-over-year; for FY2022, it was -27777.60%, down 7196.80 percentage points from FY2021.
- Across earlier years, EBIT Margin came in at -20580.80% in FY2021 (-9532.80 pp) and -11048.00% in FY2020.
- The Q1 2023 figure is the highest quarterly EBIT Margin since Q3 2020.
- On a year-over-year basis, EBIT Margin rose in 1 of the last eight quarters, with an average year-over-year change of -5045.43 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 19542.98 percentage points in Q1 2023, against a drop of 17032.26 percentage points in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -26132.26% (Q4 2022), -28648.39% (Q3 2022) and -28235.48% (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Candel Therapeutics | 711.71 Mn | 108.61 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -9,444.12% |
| Dec 31, 2022 | -26,132.26% |
| Sep 30, 2022 | -28,648.39% |
| Jun 30, 2022 | -28,235.48% |
| Mar 31, 2022 | -28,987.10% |
| Dec 31, 2021 | -24,967.74% |
| Sep 30, 2021 | -25,900.00% |
| Jun 30, 2021 | -17,100.00% |
| Mar 31, 2021 | -15,022.58% |
| Dec 31, 2020 | -19,758.06% |
| Sep 30, 2020 | -8,867.74% |
| Jun 30, 2020 | -8,448.39% |
API Access
Candel Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=CADL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "CADL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=CADL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();